Inventor · disambiguated record
Dov Shiffman
Also filed as: SHIFFMAN DOV
12 granted patents·17 pending applications·26 citations·filing 2001–2025
88Inventor score
Files withCELERA CORP12APPLERA CORP4QUEST DIAGNOSTICS INVEST LLC4BRIGHAM & WOMENS HOSPITAL3UNIV TEXAS2
Top patents by PatentIndex Score
29 records- 0187US12332236B2Methods for quantitation of insulin and C-peptideQUEST DIAGNOSTICS INVEST LLC·Filed 2024·Granted Jun 17, 2025·0 cites·19 claims
- 0286US7943317B2Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatmentBRIGHAM & WOMENS HOSPITAL·Filed 2008·Granted May 17, 2011·7 cites·21 claims
- 0385US8216786B2Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereofSHIFFMAN DOV·Filed 2009·Granted Jul 10, 2012·12 cites·30 claims
- 0482US2025271416A1Methods for quantitation of insulin and c-peptideQUEST DIAGNOSTICS INVEST LLC·Filed 2025·Application pending·0 cites
- 0581US10550433B2Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatmentBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Feb 4, 2020·2 cites·5 claims
- 0680US7977052B2Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereofCELERA CORP·Filed 2006·Granted Jul 12, 2011·2 cites·41 claims
- 0779US10584384B2Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2017·Granted Mar 10, 2020·2 cites·13 claims
- 0878US11827937B2Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2019·Granted Nov 28, 2023·0 cites·4 claims
- 0978US11697850B2Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatmentCELERA CORP·Filed 2019·Granted Jul 11, 2023·0 cites·16 claims
- 1078US2023100271A1Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2022·Application pending·0 cites
- 1177US10563263B2Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2018·Granted Feb 18, 2020·1 cites·4 claims
- 1274US12025610B2Methods for quantitation of insulin and C-peptideQUEST DIAGNOSTICS INVEST LLC·Filed 2021·Granted Jul 2, 2024·0 cites·37 claims
- 1370US11408034B2Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2020·Granted Aug 9, 2022·0 cites·16 claims
- 1468US10983108B2Methods for quantitation of insulin and C-peptideQUEST DIAGNOSTICS INVEST LLC·Filed 2018·Granted Apr 20, 2021·0 cites·29 claims
- 1568US2009264453A1Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereofCELERA CORP·Filed 2009·Application pending·0 cites
- 1664US2015284799A1Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatmentBRIGHAM & WOMENS HOSPITAL·Filed 2014·Application pending·0 cites
- 1764US2008248476A1Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereofAPPLERA CORP·Filed 2007·Application pending·0 cites
- 1862US2007042382A1Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereofAPPLERA CORP·Filed 2004·Application pending·0 cites
- 1960US2014024623A1Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatmentCELERA CORP·Filed 2013·Application pending·0 cites
- 2059US2014235605A1Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2013·Application pending·0 cites
- 2159US2014120533A1Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereofUNIV TEXAS·Filed 2013·Application pending·0 cites
- 2256US2013030051A1Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereofUNIV TEXAS·Filed 2012·Application pending·0 cites
- 2356US2011206667A1Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatmentBRIGHAM & WOMENS HOSPITAL·Filed 2011·Application pending·0 cites
- 2455US2011269735A1Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2011·Application pending·0 cites
- 2554US2009312410A1Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereofAPPLERA CORP·Filed 2007·Application pending·0 cites
- 2653US2016108473A1Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2015·Application pending·0 cites
- 2749US2006228715A1Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereofAPPLERA CORP·Filed 2005·Application pending·0 cites
- 2844US2003194721A1Genes expressed in treated foam cellsINCYTE GENOMICS INC·Filed 2002·Application pending·0 cites
- 2940US2003165924A1Genes expressed in foam cell differentiationFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dov Shiffman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →